/
Stock
/
/
APIChangelogInfo
July 4th Sale until July 8! Get 15% off!

ALIGOS THERAPEUTICS

Trade ALGS
ALGS Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-25
2025-06-26
CHAVEZ MARGARITA
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-06-25
2025-06-26
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-06-25
2025-06-26
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-06-25
2025-06-26
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-06-25
2025-06-26
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-06-25
2025-06-26
PRESTON HEATHER
A - Grant
Stock Option (Right to Buy)
5,860
$0.00
1
$44.48M
2025-02-28
2025-03-04
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
21,693
$0.00
1
$44.48M
2025-02-28
2025-03-04
CALHOUN LESLEY ANN
Chief Operating Officer and Ch...
A - Grant
Stock Option (Right to Buy)
47,271
$0.00
1
$44.48M
2025-02-28
2025-03-04
BLATT LAWRENCE
President and CEO
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$44.48M
2024-10-08
2024-10-10
ACHNECK HARDEAN
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$44.48M
2024-09-04
2024-09-06
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
33,920
$0.00
1
$44.48M
2024-09-04
2024-09-06
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
10,880
$0.00
1
$44.48M
2024-09-04
2024-09-06
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
10,880
$0.00
1
$44.48M
2024-08-07
2024-08-09
CHAVEZ MARGARITA
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$44.48M
2024-08-07
2024-08-09
PRESTON HEATHER
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$44.48M
2024-06-27
2024-06-28
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$44.48M
2024-06-27
2024-06-28
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$44.48M
2024-06-27
2024-06-28
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$44.48M
2024-06-27
2024-06-28
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$44.48M
2024-03-01
2024-03-04
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
965K
$0.00
1
$44.48M
2024-03-01
2024-03-04
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
309K
$0.00
1
$44.48M
2024-03-01
2024-03-04
MCCLURE MATTHEW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
72,000
$0.00
1
$44.48M
2024-03-01
2024-03-04
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
72,000
$0.00
1
$44.48M
2024-02-28
2024-02-28
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
153K
$0.00
3
$44.48M
2024-02-28
2024-02-28
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
8,823
$0.00
1
$44.48M
2024-02-28
2024-02-28
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
4,411
$0.00
1
$44.48M
2024-02-28
2024-02-28
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
4,411
$0.00
1
$44.48M
2024-02-28
2024-02-28
MCCLURE MATTHEW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
157K
$0.00
3
$44.48M
2024-02-28
2024-02-28
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
8,823
$0.00
1
$44.48M
2024-02-28
2024-02-28
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
4,411
$0.00
1
$44.48M
2024-02-28
2024-02-28
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
146K
$0.00
3
$44.48M
2024-02-28
2024-02-28
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
421K
$0.00
3
$44.48M
2024-02-27
2024-02-28
MARTELL BRIDGET
D - Sale to Issuer
Stock Option (Right to Buy)
-30,000
$0.00
1
$44.48M
2024-02-27
2024-02-28
BLATT LAWRENCE
Chief Executive Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-854K
$0.00
3
$44.48M
2024-02-27
2024-02-28
CALHOUN LESLEY ANN
D - Sale to Issuer
Stock Option (Right to Buy)
-307K
$0.00
3
$44.48M
2024-02-27
2024-02-28
HIRTH PETER
D - Sale to Issuer
Stock Option (Right to Buy)
-15,000
$0.00
1
$44.48M
2024-02-27
2024-02-28
MCCLURE MATTHEW
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-371K
$0.00
3
$44.48M
2024-02-27
2024-02-28
NIELSEN JACK
D - Sale to Issuer
Stock Option (Right to Buy)
-15,000
$0.00
1
$44.48M
2024-02-27
2024-02-28
NUECHTERLEIN CAROLE
D - Sale to Issuer
Stock Option (Right to Buy)
-15,000
$0.00
1
$44.48M
2024-02-27
2024-02-28
SCOPA JAMES PAUL
D - Sale to Issuer
Stock Option (Right to Buy)
-30,000
$0.00
1
$44.48M
2024-02-27
2024-02-28
SYMONS JULIAN
Executive Vice President, Chie...
D - Sale to Issuer
Stock Option (Right to Buy)
-331K
$0.00
3
$44.48M
2023-10-25
2023-10-27
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Warrants (Right to Buy)
305K
$0.00
1
$44.48M
2023-10-25
2023-10-27
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Common Stock
610K
$1.00
610K
1
$44.48M
2023-10-25
2023-10-27
SCOPA JAMES PAUL
A - Grant
Warrant (Right to Buy)
91,541
$0.00
1
$44.48M
2023-10-25
2023-10-27
SCOPA JAMES PAUL
A - Grant
Common Stock
183K
$1.00
183K
1
$44.48M
2023-10-25
2023-10-27
NUECHTERLEIN CAROLE
P - Purchase
Warrant (Right to Buy)
3.97M
$0.00
1
$44.48M
2023-10-25
2023-10-27
NUECHTERLEIN CAROLE
P - Purchase
Common Stock
7.93M
$1.00
7.93M
1
$44.48M
2023-09-08
2023-09-12
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$44.48M
2023-09-08
2023-09-12
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
48,000
$0.00
1
$44.48M
2023-09-08
2023-09-12
MCCLURE MATTHEW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
48,000
$0.00
1
$44.48M
2023-09-08
2023-09-12
QUAN LUCINDA
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
48,000
$0.00
1
$44.48M
2023-09-08
2023-09-12
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
48,000
$0.00
1
$44.48M
2023-07-20
2023-07-21
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$44.48M
2023-07-20
2023-07-21
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$44.48M
2023-07-20
2023-07-21
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$44.48M
2023-07-20
2023-07-21
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$44.48M
2023-07-20
2023-07-21
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$44.48M
2023-03-15
2023-03-17
BEIGELMAN LEONID
President
A - Grant
Stock Option (Right to Buy)
170K
$0.00
1
$44.48M
2023-03-15
2023-03-17
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
243K
$0.00
1
$44.48M
2023-03-15
2023-03-17
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
78,750
$0.00
1
$44.48M
2023-03-15
2023-03-17
MCCLURE MATTHEW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$44.48M
2023-03-15
2023-03-17
QUAN LUCINDA
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
78,750
$0.00
1
$44.48M
2023-03-15
2023-03-17
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
78,750
$0.00
1
$44.48M
2022-07-07
2022-07-11
BEIGELMAN LEONID
President
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$44.48M
2022-07-07
2022-07-11
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
162K
$0.00
1
$44.48M
2022-07-07
2022-07-11
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
52,500
$0.00
1
$44.48M
2022-07-07
2022-07-11
MCCLURE MATTHEW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
46,000
$0.00
1
$44.48M
2022-07-07
2022-07-11
QUAN LUCINDA
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
52,500
$0.00
1
$44.48M
2022-07-07
2022-07-11
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-06-23
2022-06-27
WOIWODE THOMAS
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2022-02-04
2022-02-08
BEIGELMAN LEONID
President
A - Grant
Stock Option (Right to Buy)
284K
$0.00
2
$44.48M
2022-02-04
2022-02-08
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
404K
$0.00
2
$44.48M
2022-02-04
2022-02-08
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
131K
$0.00
2
$44.48M
2022-02-04
2022-02-08
QUAN LUCINDA
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
131K
$0.00
2
$44.48M
2022-02-04
2022-02-08
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
131K
$0.00
2
$44.48M
2021-11-16
2021-11-18
MARTELL BRIDGET
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$44.48M
2021-06-17
2021-06-17
HIRTH PETER
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2021-06-17
2021-06-17
NIELSEN JACK
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2021-06-17
2021-06-17
NUECHTERLEIN CAROLE
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2021-06-17
2021-06-17
WOIWODE THOMAS
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$44.48M
2021-06-11
2021-06-15
WOIWODE THOMAS
J - Other
Common Stock
20,328
$0.00
3
$44.48M
2021-06-11
2021-06-15
WOIWODE THOMAS
J - Other
Common Stock
-504K
$0.00
3
$44.48M
2021-04-26
2021-04-28
WOIWODE THOMAS
J - Other
Common Stock
20,331
$0.00
3
$44.48M
2021-04-26
2021-04-28
WOIWODE THOMAS
J - Other
Common Stock
-504K
$0.00
3
$44.48M
2021-04-26
2021-04-27
SCOPA JAMES PAUL
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$44.48M
2020-12-01
2020-12-03
BEIGELMAN LEONID
President
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$44.48M
2020-12-01
2020-12-03
BLATT LAWRENCE
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
450K
$0.00
1
$44.48M
2020-12-01
2020-12-03
CALHOUN LESLEY ANN
A - Grant
Stock Option (Right to Buy)
176K
$0.00
1
$44.48M
2020-12-01
2020-12-03
QUAN LUCINDA
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$44.48M
2020-12-01
2020-12-03
SYMONS JULIAN
Executive Vice President, Chie...
A - Grant
Stock Option (Right to Buy)
200K
$0.00
1
$44.48M
2020-10-20
2020-10-22
NOVO HOLDINGS A/S
P - Purchase
COMMON STOCK
200K
$15.00
3.00M
1
$44.48M
2020-10-20
2020-10-22
NOVO HOLDINGS A/S
C - Conversion
SERIES A CONVERTIBLE PREFERRED STOCK
-1.61M
1
$44.48M
2020-10-20
2020-10-22
NOVO HOLDINGS A/S
C - Conversion
SERIES B -1 CONVERTIBLE PREFERRED STOCK
-564K
1
$44.48M
2020-10-20
2020-10-22
NOVO HOLDINGS A/S
C - Conversion
SERIES B -2 CONVERTIBLE PREFERRED STOCK
-241K
1
$44.48M
2020-10-20
2020-10-22
NOVO HOLDINGS A/S
C - Conversion
COMMON STOCK
2.41M
1
$44.48M
2020-10-20
2020-10-22
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series B-1 convertible Preferred Stock
-1.34M
$0.00
1
$44.48M
2020-10-20
2020-10-22
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series B-2 convertible Preferred Stock
-571K
$0.00
1
$44.48M
2020-10-20
2020-10-22
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Common Stock
1.91M
2
$44.48M
2020-10-20
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series B-2 Preferred Stock
-284K
$0.00
2
$44.48M
2020-10-20
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Common Stock
3.09M
5
$44.48M
2020-10-20
2020-10-20
VIVO CAPITAL VIII, LLC
C - Conversion
Series A Preferred Stock
-2.15M
$0.00
2
$44.48M
2020-10-20
2020-10-20
VIVO CAPITAL VIII, LLC
C - Conversion
Series B-1 Preferred Stock
-596K
$0.00
2
$44.48M
2020-10-20
2020-10-20
VIVO CAPITAL VIII, LLC
C - Conversion
Series B-2 Preferred Stock
-255K
$0.00
2
$44.48M
2020-10-20
2020-10-20
VIVO CAPITAL VIII, LLC
C - Conversion
Common Stock
3.00M
6
$44.48M
2020-10-20
2020-10-20
WOIWODE THOMAS
C - Conversion
Series A Preferred Stock
-2.15M
$0.00
1
$44.48M
2020-10-20
2020-10-20
WOIWODE THOMAS
C - Conversion
Series B-1 Preferred Stock
-663K
$0.00
2
$44.48M
2020-10-20
2020-10-20
WOIWODE THOMAS
C - Conversion
Series B-2 Preferred Stock
-284K
$0.00
2
$44.48M
2020-10-20
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
P - Purchase
Common Stock
200K
$15.00
3.00M
1
$44.48M
2020-10-20
2020-10-20
VIVO CAPITAL VIII, LLC
P - Purchase
Common Stock
550K
$15.00
8.25M
2
$44.48M
2020-10-20
2020-10-20
WOIWODE THOMAS
P - Purchase
Common Stock
200K
$15.00
3.00M
1
$44.48M
2020-10-20
2020-10-20
BEIGELMAN LEONID
President
C - Conversion
Series A Preferred Stock
-191K
$0.00
3
$44.48M
2020-10-20
2020-10-20
BEIGELMAN LEONID
President
C - Conversion
Series B-1 Preferred Stock
-57,499
$0.00
3
$44.48M
2020-10-20
2020-10-20
BEIGELMAN LEONID
President
C - Conversion
Series B-2 Preferred Stock
-24,598
$0.00
3
$44.48M
2020-10-20
2020-10-20
BEIGELMAN LEONID
President
C - Conversion
Common Stock
273K
9
$44.48M
2020-10-20
2020-10-20
BLATT LAWRENCE
Chief Executive Officer
C - Conversion
Series A Preferred Stock
-191K
$0.00
4
$44.48M
2020-10-20
2020-10-20
BLATT LAWRENCE
Chief Executive Officer
C - Conversion
Series B-1 Preferred Stock
-57,500
$0.00
3
$44.48M
2020-10-20
2020-10-20
BLATT LAWRENCE
Chief Executive Officer
C - Conversion
Series B-2 Preferred Stock
-24,599
$0.00
3
$44.48M
2020-10-20
2020-10-20
BLATT LAWRENCE
Chief Executive Officer
C - Conversion
Common Stock
273K
10
$44.48M
2020-10-20
2020-10-20
NUECHTERLEIN CAROLE
C - Conversion
Series A Preferred Stock
-2.15M
$0.00
1
$44.48M
2020-10-20
2020-10-20
NUECHTERLEIN CAROLE
C - Conversion
Series B-1 Preferred Stock
-663K
$0.00
1
$44.48M
2020-10-20
2020-10-20
NUECHTERLEIN CAROLE
C - Conversion
Series B-2 Preferred Stock
-284K
$0.00
1
$44.48M
2020-10-20
2020-10-20
NUECHTERLEIN CAROLE
C - Conversion
Common Stock
3.09M
3
$44.48M
2020-10-20
2020-10-20
QUAN LUCINDA
C - Conversion
Series A Preferred Stock
-6,835
$0.00
1
$44.48M
2020-10-20
2020-10-20
QUAN LUCINDA
C - Conversion
Series B-1 Preferred Stock
-1,697
$0.00
1
$44.48M
2020-10-20
2020-10-20
QUAN LUCINDA
C - Conversion
Series B-2 Preferred Stock
-726
$0.00
1
$44.48M
2020-10-20
2020-10-20
QUAN LUCINDA
C - Conversion
Common Stock
9,258
3
$44.48M
2020-10-20
2020-10-20
SYMONS JULIAN
C - Conversion
Series A Preferred Stock
-13,671
$0.00
1
$44.48M
2020-10-20
2020-10-20
SYMONS JULIAN
C - Conversion
Series B-1 Preferred Stock
-3,394
$0.00
1
$44.48M
2020-10-20
2020-10-20
SYMONS JULIAN
C - Conversion
Series B-2 Preferred Stock
-1,452
$0.00
1
$44.48M
2020-10-20
2020-10-20
SYMONS JULIAN
C - Conversion
Common Stock
18,517
3
$44.48M
2020-10-20
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series A Preferred Stock
-2.15M
$0.00
1
$44.48M
2020-10-20
2020-10-20
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series B-1 Preferred Stock
-663K
$0.00
2
$44.48M
2020-10-20
2020-10-20
WOIWODE THOMAS
C - Conversion
Common Stock
3.09M
5
$44.48M